COLLEGE ON PROBLEMS OF DRUG DEPENDENCE MEETING (1999)

药物依赖问题学院（CPDD）将举办第61届 年度科学会议在阿卡普尔科的阿卡普尔科公主酒店举行， 墨西哥，1999年6月12日至17日。 将有5天的 科学会议，将由志愿者口头 演讲，海报会议，和12或13个及时的研讨会。 特别 注意青年科学家、受训人员、学生 和代表性不足的人群。 这种关注是必要的 以确保药物滥用领域的科学家队伍不断壮大。 会议的一个重点将是墨西哥的药物滥用问题， 它们与美国的问题有什么关系。 会有一个好 代表药物滥用研究的所有领域和专题的平衡 社区 虽然最后的专题讨论会的选择将不会由 1998年秋季之前，在CPDD方案委员会的名单中， 已经提交并正在审议的专题讨论会和主席 计划委员会的考虑如下：小说 与阿片系统有关的物质：孤啡肽和 内吗啡肽，主席：胡达阿基勒;药物使用和 后果，主席：克莱德麦考伊;精神兴奋剂诱导的基因 药物，椅子：迈克尔·库哈尔和斯科特·麦克勒;药物使用和成瘾 作为一种新出现的疾病，主席：亨利弗朗西斯和菲利普彼得森; 现实生活中药物滥用治疗的应急管理，主席：莱斯利 Amass和Martin Iguchi;海洛因新疗法的滥用责任 成瘾，主席：桑迪科默;药物滥用对趋化因子的影响， 细胞因子和感染，主席：托比爱森斯坦和芭芭拉拜耳; 治疗过程研究：患者动机，参与， 保留和成果，主席：Dwayne Simpson。 全体会议和颁奖讲座以及几次卫星会议， 专业研讨会将完成该计划。 过程将 将作为档案NIDA专著出版，并将邮寄给所有 会议注册人和所有NIDA赠款人。

The College on Problems of Drug Dependence (CPDD) will hold its 61st Annual Scientific Meeting at the Acapulco Princess Hotel in Acapulco, Mexico, from June 12 through June 17, 1999. There will be 5 days of scientific sessions which will be made up of volunteer oral presentations, poster sessions, and 12 or 13 timely symposia. Special attention is given to the needs of young scientists, trainees, students, and underrepresented populations in the field. Such attention is needed to insure a continued cadre of scientists for the field of drug abuse. One emphasis of the meeting will be on drug abuse problems in Mexico and how they relate to problems in the United States. There will be a good balance of all fields and topics representing the drug abuse research community. Although final symposia choices will not be made by the Program Committee of CPDD until the fall of 1998, among the list of symposia and chairs that have already been submitted and are under consideration by the Program Committee are the following: Novel Substances Related to the Opioid System: An Update on the Orphanins and the Endomorphins, Chair: Huda Akil; The Epidemiology of Drug Use and Consequences, Chair: Clyde McCoy; Genes Induced by Psychostimulant Drugs, Chairs: Michael Kuhar and Scott Mackler; Drug Use and Addiction as an Emerging Disease, Chairs: Henry Francis and Phillip Peterson; Contigency Management for Real-life Drug Abuse Treatment, Chairs: Leslie Amass and Martin Iguchi; Abuse Liability of New Treatments for Heroin Addiction, Chair: Sandy Comer; Effects of Drugs of Abuse on Chemokines, Cytokines, and Infection, Chairs: Toby Eisenstein and Barbara Bayer; Treatment Process Studies: Findings on Patient Motivation, Engagement, Retention, and Outcomes, Chair: Dwayne Simpson. Plenary and award lectures as well as several satellite meetings and speciality workshops will complete the program. The Proceedings will be published as an archival NIDA monograph and will be mailed to all meeting registrants and to all NIDA grantees.